Table 2.
sTILs Continuous Variable | sTILs Stratified Variable | |||||||
---|---|---|---|---|---|---|---|---|
Univariate Analyses | Multivariate Analyses * | Univariate Analyses | Multivariate Analyses * | |||||
OR (95% CI ) | p | OR (95% CI ) | p | OR (95% CI ) | p | OR (95% CI ) | p | |
pCR | 1.22 [1.05; 1.42] | 0.010 | 1.20 [1.00; 1.43] | 0.046 | 4.46 [1.35; 14.80] | 0.011 | 3.73 [1.01; 13.74] | 0.048 |
MPbreast | 1.18 [1.04; 1.34] | 0.013 | 1.17 [1.02; 1.35] | 0.027 | 2.62 [1.16; 5.96] | 0.022 | 2.45 [1.02; 5.88] | 0.045 |
MPaxilla | 1.05 [0.93; 1.19] | 0.458 | 1.46 [0.70; 3.05] | 0.324 | ||||
RCB | 1.11 [0.98; 1.26] | 0.110 | 1.43 [0.69; 2.95] | 0.333 |
sTILs: stromal tumour-infiltrating lymphocytes, pCR: pathological complete response, MP: Miller and Payne, RCB: residual cancer burden, OR: odds ratio, CIs: confidence intervals. sTILs stratified variable: high-TILs (>10%) vs. low-TILs (≤10%); Responders: pCR ypT0/is ypN0, MP-4/5 and MP-A/D, and RCB 0; Non-responders: non-pCR, MP-1/2/3 and MP-B/C, and RCB I/II and III. * The multivariate analyses included histological grade (G3 vs. G1/G2), tumour size (T2/T3/T4 vs. T1), lymph node status (N+ vs. N0), and molecular subtype (luminal-A, luminal-B, TNBC) as covariates. The statistical parameters shown in the table refer to sTILs (continuous and stratified variables). Statistically significant p-values are marked in bold.